HeartSciences Inc.
HSCS
$3.46
$0.113.28%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | 149.15% | 830.00% | 257.69% | 100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | 149.15% | 830.00% | 257.69% | 100.00% |
| Cost of Revenue | -100.00% | 100.00% | 662.50% | 117.86% | 48.78% |
| Gross Profit | -100.00% | 180.56% | 941.67% | 420.83% | 135.85% |
| SG&A Expenses | 3.78% | 5.59% | 3.01% | -5.88% | 14.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.54% | 28.65% | 17.52% | 3.37% | -7.05% |
| Operating Income | -37.97% | -28.53% | -17.25% | -3.15% | 7.20% |
| Income Before Tax | -33.26% | -25.20% | -18.58% | -3.95% | 5.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33.26% | -25.20% | -18.58% | -3.95% | 5.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.26% | -25.20% | -18.58% | -3.95% | 5.66% |
| EBIT | -37.97% | -28.53% | -17.25% | -3.15% | 7.20% |
| EBITDA | -37.90% | -28.53% | -17.25% | -3.15% | 7.21% |
| EPS Basic | 78.98% | 82.76% | 64.33% | 57.86% | 61.69% |
| Normalized Basic EPS | 78.98% | 82.76% | 64.33% | 57.86% | 61.69% |
| EPS Diluted | 78.98% | 82.76% | 64.33% | 57.86% | 61.69% |
| Normalized Diluted EPS | 78.98% | 82.76% | 64.33% | 57.86% | 61.69% |
| Average Basic Shares Outstanding | 289.32% | 638.00% | 472.61% | 344.76% | 237.02% |
| Average Diluted Shares Outstanding | 289.32% | 638.00% | 472.61% | 344.76% | 237.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |